Ligand Pharma (LGND) PT Lowered to $175 at Roth Capital

September 2, 2022 8:58 AM EDT Send to a Friend

Roth Capital analyst Scott Henry ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Ligand Pharma (LGND) PT Lowered to $175 at Roth Capital

Member Login

Free News Feed